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Wednesday, February 29, 2012 663ainflux via NCX. Thus, YM-244769 has therapeutic potential as an efficient re-
noprotective drug.
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Pseudohypoaldosteronism type II (PHAII) is an autosomal dominant disease
characterized by hypertension due to increased renal salt reabsorption. Cush-
ing’s syndrome is associated with excessive cortisol secretion by ectopic
ACTH producing tumor and may result in hypertension. Here we examined
the role of Naþ/Ca2þ exchanger type-1 (NCX1) in hypertension of these model
mice using specific NCX inhibitors and genetically engineered mice. NCX in-
hibitors lowered arterial hypertension in WNK4 mutant knockin mice (present-
ing the phenotype of PHAII) and chronically ACTH-administered mice.
Furthermore, heterozygous knockout of NCX1 was resistant to development
of hypertension in these model mice, whereas vascular overexpression of
NCX1 accelerated their hypertension. Since NCX inhibitors reversed the cyto-
solic Ca2þ elevation and vasoconstriction induced by nanomolar ouabain, cir-
culating endogenous cardiac glycosides may be involved in hypertension of
these model mice. Thus, vascular NCX1 contributes to hypertension in PHAII
and Cushing’s syndrome, and NCX inhibitors might be therapeutically useful
for their hypertension.
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Intracellular Ca2þ concentration [Ca2þ]i and intracellular Na
þ concentration
[Naþ]i were elevated in swine (RyR1-R615C) and rodent (RyR1-R163C)
MH susceptible (MHS) compared to Wt (MHN) muscle fibers. In both MHN
and MHS muscle fibers stepwise reduction of external [Naþ] gradually in-
creased [Ca2þ]i, which could be prevented by removal of extracellular Ca
2þ
([Ca2þ]ext). Disruption of the T-system by glycerol treatment also reduced
the magnitude of the [Ca2þ]i elevation induced by Na
þ free solution in both
groups. Administration of KBR7943 reduced [Ca2þ]i in MHN and MHS mus-
cle fibers, and ameliorated the magnitude of the elevation of [Ca2þ]i observed
during a MH episode. However, YM-2444769 an NCX blocker that preferen-
tially inhibits NCX3 reverse mode did not reduce [Ca2þ]i in either MHN or
MHS muscle fibers at rest, but did reduce the amplitude of the elevation
[Ca2þ]i induced by halothane in R163C MHS muscle fibers. These results sup-
port the existence of a functional NCX reverse mode in pig and mouse skeletal
muscle, which appears to be enhanced in MHS muscle fibers, and shows that
the majority of NCX is localized in the T-tubule. They further show that
NCX in its reverse mode contributes to the elevation of [Ca2þ]i in MHS muscle
during exposure to halothane.
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The cardiac sodium-calcium exchanger (NCX1) is hypothesized to play a ma-
jor role in sinoatrial node (SAN) pacemaker activity. To test this hypothesis
directly, we used cre/loxP technology to generate an atrial-specific knockout
(KO) of NCX1 in mice using the sarcolipin promoter. At 12 weeks, there is no
evidence of NCX1 in the atrium or SAN by immunostaining or immunoblot.
KO mice exhibit atrial dilation and ventricular hypertrophy with mild ventric-
ular dysfunction. On electrocardiography, KO mice have no P waves and a rel-
atively slow junctional escape rhythm (231 5 16 bpm, n = 4) compared to
normal sinus rhythm in WT (422 5 63 bpm, n = 2; p = 0.01). Furthermore,
recordings of cardiac electrograms in Langendorff-perfused hearts show no
evidence of atrial activity in KO. In patch clamped SAN cells isolated from
KO mice, there is no NCX activity in response to caffeine-induced SR
Ca2þ release. L-type Ca2þ current is decreased in KO by ~50% but there is
no significant difference in funny current (If) amplitude between WT andKO. Spontaneous action potentials (APs) are absent in KO, even after appli-
cation of isoproterenol (ISO, 1mM). However, we were still able to evoke APs
in patch clamped KO cells under current clamp conditions, indicating that KO
cells are capable of electrically stimulated depolarization. The maximum di-
astolic potential (MDP) was slightly more depolarized in KO (- 57 5 2.0
mV) compared to WT (- 705 2.5 mV, p < 0.001), which could theoretically
reduce spontaneous activity. However, reducing extracellular Kþ to lower the
MDP in KO to WT values failed to restore rhythmic pacemaker activity.
Thus, we conclude that NCX1 is required for normal pacemaker activity in
the murine SAN.
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Insulin not only stimulates the Na-K-pump,but by stimulating the Na:H ex-
change pump increases intracellular pH, pHi. Fidelman et al (1982) found, as
predicted by thermodynamic theory, the effect of insulin on glycolysis varied
linearly with log[Na]o with the insulin effect being converted from stimulation
of glycolysis to a 51% inhibition at 0.12 mM Nao.
Zierler & Rabinowitz (1964) demonstrated in the forearm of human males that
levels of insulin too low to affect glucose uptake, as little as 38 micro units
per ml, was sufficient to stimulate the Na-K-pump, as reflected by increased po-
tassium uptake, while producing no effect upon glucose uptake. This one exper-
iment forces us to realize that the main action of insulin is not to regulate blood
glucose levels, but to regulate the Na-K-pump and Na:H exchange. Since the
Na-K-pump uses about 25% of the ATP production in a resting muscle, stim-
ulation of the Na-K-pump increases the consumption of ATP so much that at
high levels of stimulation, it is necessary to get more glucose into the cell to
manufacture more ATP.
Since insulin decreases Nai, elevates pHi, and increases production of ATP, one
would expedt that the decreased insulin, such as seen in diabetes or in fasting
would result in the reverse of these changes. Lowering plasma levels of insulin
in rats by small doses of streptozotocin or by fasting produced an increase in
Nai of about 30%, a decrease in pHi of 0.15 units, and a 24% decrease in ATPi.
The action of thiazide diuretics to cause type 2 diuretics has been shown to be
due to their ability to cause potassium loss. Not surprisingly, diets with large
amounts of potassium and small amounts of sodium have been shown to reverse
diabetes.
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Sodium-hydrogen exchanger (NHE), the principal sarcolemmal acid extruder
in ventricular myocytes is stimulated by a variety of autocrine/paracrine fac-
tors and contributes to myocardial injury and arrhythmias during ischemia/
reperfusion (IR). Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-
glycero-3-phosphocholine) is a potent proinflammatory phospholipid that is
released in the heart in response to oxidative stress and promotes myocardial
IR injury. PAF stimulates NHE in neutrophils and platelets, but its effect on
cardiac NHE (NHE1) is resolved. We utilized quiescent guinea pig ventricular
myocytes bathed in icarbonate-free solutions and used epifluorescence to mea-
sure intracellular pH (pHi). Methylcarbamyl-PAF (C-PAF, 200 nM), a meta-
bolically-stable analog of PAF, significantly increased steady-state pHi. The
alkalosis was completely blocked by the NHE inhibitor, cariporide, and by
sodium-free bathing solutions, indicating it was mediated by NHE activation.
C-PAF also significantly increased the rate of acid xtrusion induced by intra-
cellular acidosis. The ability of C-PAF to increase steady-state pHi was
completely blocked by the PAF receptor inhibitor WEB 2086 (10 mM), indi-
cating the PAF receptor is required. A mitogen-activated protein (MAP) ki-
nase kinase (MEK) inhibitor (PD98059, 25mM), also completely blocked
the rise in pHi induced by C-PAF, suggesting participation of the MAP kinase
signaling cascade downstream of the PAF receptor. Inhibition of protein
kinase C (PKC) with GF109203X (1 mM) and chelerythrine (2 mM) did not
significantly affect the alkalosis induced by C-PAF. In summary, these results
provide evidence that: a) PAF stimulates cardiac NHE1, b) the effect occurs
via the PAF receptor, and c) signal relay requires participation of the MAP
kinase cascade.
